Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Imaging in Patients With Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01816048
What this trial is testing

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

Who this might be right for
Prostatic NeoplasmsProstate Cancer
University of Wisconsin, Madison 8
Not applicableStudy completedNCT03368547
What this trial is testing

68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v7Stage III Prostate Cancer AJCC v7+1 more
Jonsson Comprehensive Cancer Center 400
Not applicableStudy completedNCT06836154
What this trial is testing

Prostate Hyperfixation on PET-choline in Patients With Prostate Cancer: Correlation With MRI and Pathological Data (LOC-CHOLINE)

Who this might be right for
Prostatic Neoplasms
University Hospital, Brest 70
Not applicableActive Not RecruitingNCT04030338
What this trial is testing

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Who this might be right for
Prostate CancerProstate NeoplasmProstate Adenocarcinoma+2 more
Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Ended earlyNCT01119118
What this trial is testing

ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 6
Not applicableActive Not RecruitingNCT06523777
What this trial is testing

PRISM: Patient Experiences With PET Imaging in Prostate Cancer

Who this might be right for
Prostate Cancer
Yale University 350
Not applicableLooking for participantsNCT07568613
What this trial is testing

Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prostate Cancer

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 50
Large-scale testing (Phase 3)Looking for participantsNCT04423211
What this trial is testing

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate CarcinomaProstate Adenocarcinoma+1 more
ECOG-ACRIN Cancer Research Group 804
Not applicableLooking for participantsNCT00588185
What this trial is testing

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 300
Not applicableStudy completedNCT02856100
What this trial is testing

Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Large-scale testing (Phase 3)Study completedNCT02659527
What this trial is testing

PET/MRI in Patients With Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna 220
Testing effectiveness (Phase 2)Study completedNCT01923727
What this trial is testing

Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
ImaginAb, Inc. 38
Testing effectiveness (Phase 2)Looking for participantsNCT07237269
What this trial is testing

Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

Who this might be right for
Prostate Cancer
University of Nebraska 140
Not applicableActive Not RecruitingNCT06580015
What this trial is testing

[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer

Who this might be right for
Prostate Carcinoma
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05849298
What this trial is testing

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Who this might be right for
Prostatic Neoplasm
Novartis Pharmaceuticals 49
Large-scale testing (Phase 3)Study completedNCT06754085
What this trial is testing

Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer
HTA Co., Ltd. 131
Not applicableNo Longer AvailableNCT03501940
What this trial is testing

F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaPSA Level Greater Than 0.2PSA Level Greater Than or Equal to Two+2 more
Andrei Iagaru
Early research (Phase 1)UnknownNCT06062355
What this trial is testing

Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 9
Testing effectiveness (Phase 2)Looking for participantsNCT06474806
What this trial is testing

Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer

Who this might be right for
Prostate Cancer
Curasight 168
Testing effectiveness (Phase 2)Ended earlyNCT02483884
What this trial is testing

PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

Who this might be right for
Prostate Cancer
Lantheus Biosciences Ltd. 30
Next Page